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Exercise is the archetype of physiologic demands placed on the cardiovascular system. Acute responses
provide an informative assessment of cardiovascular function and fitness, while repeated exercise promotes
cardiovascular health and evokes important molecular, structural, and functional changes contributing to its
effects in primary and secondary prevention. Here we examine the use of exercise in murine models, both
as a phenotypic assay and as a provocative intervention. We first review the advantages and limitations of
exercise testing for assessing cardiac function, then highlight the cardiac structural and cellular changes
elicited by chronic exercise and key molecular pathways that mediate these effects.Acute Exercise as a Cardiovascular Phenotyping Tool
Why use exercise to phenotype the heart? The cardiac response
to exercise can be viewed as a critical functional metric by
which to gauge the effect of a cardiac intervention. While resting
contractile function, assessed by echocardiography, is the most
common functional measure used in animal studies, it can be an
inadequate readout. For example, resting contractile function is
normal both after exercise training and in the disease Heart Fail-
ure with Preserved Ejection Fraction. So in these cases, it pro-
vides little functional information about the cardiac effects of
training or disease. Direct measure of cardiac function during ex-
ercise would be ideal, but in the mouse such measurements are
generally impractical. Instead, exercise capacity has often been
employed as a surrogate. Given the importance of assessing
cardiac function in mouse models of cardiovascular disease
or exercise training, we will review the measurement of exercise
capacity and the logical premises implicit in its use as a surro-
gate of exercise-cardiac function. We pay particular attention
to the experimental factors that influence its interpretation,
reproducibility, and the ability to compare measurements across
studies.
The essence of the cardiac response to exercise is an in-
crease in cardiac output elicited by an increase in workload
(‘‘exercise-cardiac output’’). Recently, Lujan and DiCarlo have
succeeded in directly measuring this response in the unre-
strained, unanesthetized mouse, at rest and while running on
the treadmill, noting a 2-fold rise in cardiac output with exercise
(Lujan and DiCarlo, 2013). Diagnosing the cause of a depressed
exercise-cardiac output can be challenging as it could arise
from pathology intrinsic or extrinsic to the heart (Rowell et al.,
1996). Extra-cardiac contributors to cardiac output include the
skeletal muscle pump, vascular, and nervous system responses
to exercise. Furthermore, it is not yet feasible to even measure
all of these component responses while a mouse is exercising.
The diagnostic challenge is greatly simplified when the interven-
tion of interest specifically targets the heart. Though it remains
technically challenging to measure the intervention’s effect on
exercise-cardiac output, in this setting a change in exercisecapacity can serve as a reasonable surrogate since it directly
depends on cardiac output. The measurement of exercise ca-
pacity is much more tractable from a technical perspective,
but entails a number of interpretive challenges to which we
now turn.
Exercise Capacity Measurement
The measurement of exercise capacity depends on three key
elements: an exercise stimulus, an assessment of exhaustion,
and a measure of exercise capacity. Examples of these might
be forced treadmill running at a fixed speed, ‘‘looks exhausted,’’
and total distance run, respectively. To minimize the influence
of volition on exercise capacity, we only consider forced exercise
stimuli, in particular treadmill running. Unfortunately there are no
agreed-upon standards for the three assay ingredients (Booth
et al., 2010). As a result, published values of exercise capacity
may be difficult to reproduce and to compare across studies
that employ different protocols. Perhaps surprisingly, even
within a study, different exercise protocols applied to the same
mice can lead to dramatically different exercise capacities.
Each of the three assay elements influences exercise capacity
through rich ties to the underlying physiology, connections we
summarize below.
Assessing Exhaustion
Given the obvious communication barrier, assessing exhaustion
in a mouse can be particularly challenging. A mouse could stop
exercising due to fear, distraction, depression, laziness, joint
pain, heightened perception of muscle pain, or fatigue, to
name a few reasons. Ideally, an exercise protocol for assessing
cardiac function would define exhaustion in such a way as to
automatically eliminate all reasons for stopping except fatigue.
The most common practice is to conclude an animal is ex-
hausted when, despite prodding, it stops running for 5–10 s.
It’s unclear, however, whether this criterion adequately discrim-
inates among the myriad potential causes of exercise cessation
(Booth et al., 2010). Though absolute confidence in the cause of
exercise cessation is impossible, investigators have put forward
at least four techniques that enrich for fatigue as the cause (CoppCell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 227
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Figure 1. The Power-Work Relationship and Its Implications for
Exercise Testing
(A) Power-work relationship. During constant power exercise at a work rate of
P milliwatts, the amount of work that can be completed before exhaustion (W,
the exercise capacity) is a function of the parameters P, CP, and AWC. For P <
CP, termed theModerate or Heavy workzones,W is theoretically unlimited. For
P > CP, termed the Severe workzone, W follows the displayed power-work
relation. The example value of CP was calculated for a 25-g mouse with a
critical velocity of 22 m/min on a 10 treadmill incline; AWC was set at 2 joules.
(B) Workload dependence of relative exercise capacity between two groups of
mice, treatment (green) and control (blue). The ratio of exercise capacities is a
function of the imposed workload, P, displayed here for two different values
within zone C (thick gray dashed lines). It also depends on the power-work
parameters of each group: CP1, CP2, and AWC. AWC is assumed equal be-
tween groups. See text for details. CP, critical power; AWC, anaerobic work
capacity.
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zation and pre-test warm-up periods, together with adequate
motivation during exercise, can mollify or simply overpower psy-228 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.chological barriers to exercise. Second, investigators can learn
the behavioral patterns a mouse exhibits on the treadmill and
how it looks when tiring, judging this by inescapable analogy to
human experience. Using pre-specified criteria, individual exer-
cise bouts or even entire mouse strains should be eliminated
from consideration when aberrant exercise behavior is seen or
lack of overt fatiguing behavior is appreciated. Third, confidence
in subjective assessments can be enhanced by employing a
biochemical assay of exhaustion such as elevated circulating
lactate measured from a drop of tail blood. Finally, the reproduc-
ibility of the measured exercise capacity should be assessed.
Poor reproducibility suggests that multiple uncontrolled factors
are contributing to the exhaustion assessment.
Exercise Capacity Metrics
The actual measure of exercise capacity is typically expressed
either in terms of the workload performed or the workload’s ef-
fect on the animal’s physiology (Wasserman, 2012). Examples
include total mechanical work completed (joules), peak power
achieved (joules/s = watts), or peak oxygen consumption (ml
O2/min). Not infrequently, surrogates of workload are reported
such as total distance traveled or total time on the treadmill.
However, when data on the weight of the animals or incline angle
of the treadmill are omitted, it is impossible to reconstruct the
actual workload performed. In these cases reported exercise
capacities cannot be meaningfully compared across studies.
Peak oxygen consumption (VO2) is a commonly used measure
of exercise capacity in humans, often considered the gold
standard. In mice, however, it is a more expensive and techni-
cally demanding measurement. For this reason, it is reported in
a minority of studies.
Workload Dependence of Exercise Capacity
The nature of the exercise itself can have a profound influence on
themeasured exercise capacity, due to a nonlinearity of exercise
physiology known as the ‘‘critical power’’ (CP) concept (Figure 1)
(Jones et al., 2010; Morton, 2006; Poole and Jones, 2012). In
treadmill running, exercise workload is determined by the incline
angle and belt speed schedule, i.e. the change in treadmill speed
over time. When combined with an animal’s weight these proto-
col conditions determine its power output (in watts). The physi-
ology of CP is most readily illustrated by constant workload
tests, wherein the treadmill speed is rapidly increased to a pre-
determined value and then fixed there for the duration of the
test. ‘‘Critical velocity’’ (CV) is that constant speed below which
exercise cessation due to fatigue does not occur. CP is the
animal’s power output at that speed. For an animal exercising
below its CP, metabolic homeostasis can bemaintained, as indi-
cated by steady states of intramyocyte lactate, creatine phos-
phate, H+, and oxygen consumption (Jones et al., 2008; Poole
et al., 1988). In theory, exertion could continue indefinitely under
these conditions except for the eventual exhaustion of metabolic
fuel reserves. In practice, exercise cessation below the CP
occurs due to an incompletely understood mix of influences
thought to be unrelated to fatigue, and exercise duration under
these conditions is highly variable (Copp et al., 2009). In contrast,
at any power output above CP fatigue will always occur. More-
over, the higher the treadmill speed is relative to the CV, the
less total work that can be performed, in a hyperbolic power-
work relationship (Figure 1A) (Morton, 2006). Biochemically,
above the CP, intracellular metabolites such as lactate and
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sumption (VO2) they rise inexorably to some peak value at
exhaustion. As illustrated in Figure 1A, a second parameter is
needed to fully determine the CP curve, often termed the anaer-
obic work capacity (AWC). Intuitively AWC is thought to reflect
the total work that can be performed using anaerobic energy
stores, though precisely what it measures is a subject of ongoing
investigation (Morton, 2006). These properties reflect a funda-
mental biochemical threshold marked by the CP, a threshold
that can be modified by exercise training as well as disease
states (Jenkins and Quigley, 1992; Mezzani et al., 2010). Further-
more, while first studied in humans (Moritani et al., 1981), the CP
model has also been validated in other species (Lauderdale and
Hinchcliff, 1999), including mice (Billat et al., 2005) and rats
(Copp et al., 2010a).
The workload dependence of exercise capacity is most
acutely illustrated when comparing two groups of mice without
knowledge of their respective CP parameters. Figure 1B shows
three workload zones demarcated by the CP parameters of
two hypothetical mouse groups, ‘‘treatment’’ and ‘‘control.’’
From the preceding discussion it’s clear that if both groups are
exercised at a fixed workload that lies in zone A, below the CP
of both, neither group will fatigue, and their measured exercise
capacities will be subject to an unpredictable, and possibly irre-
producible, set of factors. If the imposed workload is in zone B,
the control mice will fatigue, but the treatment mice will not,
theoretically leading to an unbounded relative exercise capacity.
If the chosen workload lies in zone C, above the CP for both
groups, then neither of these extreme and highly variable behav-
iors will occur. However, note that the measured effect size
of treatment (e.g., exercise capacity ratio between the groups)
differs dramatically depending on magnitude of the workload
relative to each group’s CP parameter. We have so far assumed
the AWC parameter to be equal between groups. If we remove
this simplifying assumption and group AWCvalueswere to differ,
then theoretically even the direction of the treatment effect could
depend on the workload imposed. The alarming conclusion is
that different choices of a preset constant workload could in
principle result in wildly different relative measures of exercise
capacity depending on the underlying exercise physiology (CP,
AWC), which is typically unknown before testing (Whipp and
Ward, 2009).
An incremental exercise test, wherein the treadmill speed
increases over time, avoids some, but not all, of these pitfalls.
Since the treadmill speed will eventually surpass the CV of
both groups, the unreliable results inherent in zone A and zone
B cannot occur. However, the effect size of the treatment on ex-
ercise capacity will continue to be workload dependent, in this
setting determined by the pace at which the treadmill speed in-
creases (‘‘ramp slope’’) (Morton, 1994). Peak VO2, as an alterna-
tive measure of exercise capacity, is also workload dependent,
but may be more robust than total work. In particular, as long
as the workload is above CP, but not ‘‘excessive,’’ VO2 will rise
to the same peak value no matter the workload (Gaesser and
Poole, 1996). Unfortunately it is not completely invariant to work-
load above CP. In humans at least, an extremely high workload
(in the so-called extreme workzone) will rapidly lead to fatigue
at a peak VO2 which is lower than that achieved at more modest
workloads above CP (Poole and Jones, 2012).The workload dependence of exercise capacity measure-
ments makes it difficult to compare values across studies that
employ different protocols. Moreover, the parameters that deter-
mine workload, most commonly the treadmill incline angle and
speed ramp slope, do in fact vary considerably between studies
and often seem arbitrarily chosen. Perhaps the most protocol-
invariant measure of exercise capacity would be CP itself,
together with the closely related AWC (in essence the ability to
reconstruct the entire power-work curve). Although not a capac-
ity in the traditional sense of measuring peak physical ability, CP
is the maximum work rate at which a near biochemical steady
state can bemaintained. Despite its attractive invariance proper-
ties, CP has rarely been used for this purpose in animal studies to
date (Mille-Hamard et al., 2012). Finally, its relationship to the ex-
ercise-cardiac response isworthy of further exploration (Mezzani
et al., 2010).
Exercise Capacity as a Surrogate of Exercise-Cardiac
Output
If exercise capacity is reduced by a cardiac-restricted interven-
tion, is that sufficient evidence to conclude that peak exercise-
cardiac output is reduced? While likely, there are at least two
other explanations. First, the intervention could create an unde-
sirable tradeoff between augmentation of cardiac output and
another response that could itself cause the cessation of exer-
cise. For example, if the intervention were to reduce cardiac
compliance, then augmenting stroke volume would require
higher filling pressures, which is commonly believed to cause
shortness of breath. This in turn could lead to cessation of exer-
cise before cardiac output is maximized. Although peak cardiac
output is reduced in this scenario, this would not be the primary
cause of exercise intolerance, but rather a consequence of
stopping early (Houstis and Lewis, 2014). Second, a range of
secondary non-cardiac changes that occur as a consequence
of chronically reduced cardiac output can impair exercise ca-
pacity. For example, defects in skeletal muscle oxygen extrac-
tion that occur after myocardial infarction (MI) (Esposito et al.,
2010) could influence exercise capacity, complicating the quan-
titative interpretation of the cause of exercise intolerance. To be
sure, neither of these examples impugns the causality of the
intervention, nor that its effect stems from the heart. They simply
illustrate that there are more complex ways for the heart to influ-
ence exercise capacity beyond a reduction in exercise-cardiac
output.
Does reduced cardiac output always cause exercise intoler-
ance? In theory, this could only be avoided if there were a mech-
anism to compensate for the loss of cardiac output. In fact, the
periphery is able to extract more oxygen when cardiac output
is lower due to longer diffusion times. However, this compensa-
tion is not complete, and though buffered by the boost in extrac-
tion (Wagner, 2011), exercise capacity will still suffer. Of course
in practice, a particular exercise protocol might be relatively
insensitive to modest changes in exercise-cardiac output, espe-
cially given the dependence on exercise conditions discussed
above.
When exercise intolerance is caused by interventions that
are not heart restricted, determining the cardiac contribution is
significantly more challenging since multiple organ systems
couldbe at play. It is therefore difficult in this setting to confidentlyCell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 229
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measuring exercise-cardiac output. More commonly, an indirect
inference ismadebydocumenting a reduction in exercise capac-
ity and cardiac abnormalities at rest, frequently by echocardiog-
raphy. The potential pitfalls of using this approach are illustrated
by a recent paper using two models of a cardiac-specific inter-
vention, MI and pressure overload (thoracic aortic constriction)
(Richards et al., 2013). The surrogate of exercise-cardiac output
they used was isoproterenol-induced changes in cardiac output
and ejection fraction, as measured by MRI in anesthetized mice.
As predicted, isoproterenol was effective at eliciting ‘‘cardiac
reserve,’’ increasing both cardiac output and ejection fraction.
However, there was virtually no correlation between the isopro-
terenol-induced effects on these measures and the exercise
capacity of the mice, and by inference no relationship with
exercise-cardiac output. In humans it is well appreciated that
pharmacologic stress can only recapitulate a subset of the
cardiovascular response to exercise. As demonstrated by the
thorough study by Richards et al., these limitations appear to
apply to mice as well.
As we have discussed, models of acute exercise can be
powerful tools for assessing cardiac function. Exercise can be
more than just a measurement tool though; sustained exercise
can be a powerful modifier of cardiac performance. We now
turn our discussion to the molecular, cellular, and architectural
adaptations of the heart to chronic exercise training, with a
particular focus on the beneficial effects of exercise and the
mechanisms thought to underlie them.
Adaptations to Chronic Exercise
Exercise has well-documented clinical benefits in the prevention
and treatment of cardiovascular disease (Lavie et al., 2009;
Lawler et al., 2011; Taylor et al., 2004). Exercise both reduces
numerous cardiovascular risk factors including diabetes mellitus
(LeBrasseur et al., 2011), hyperlipidemia (Mannu et al., 2013),
and hypertension (Pal et al., 2013), and benefits patients with
existing heart disease, potentially with a similar degree of effect
on mortality reduction as many drug interventions (Naci and
Ioannidis, 2013). In patients with heart failure exercise improves
measures of cardiac performance (Haykowsky et al., 2007),
self-reported health status (Flynn et al., 2009), and outcomes
including rates of re-infarction and mortality, both cardiac and
all-cause (Lawler et al., 2011; O’Connor et al., 2009). These
improvements are modest (O’Connor et al., 2009), which could
be related to limited efficacy of such interventions, the specific
protocols employed, and/or imperfect compliance. Of course,
the sickest patients are least capable of vigorous exercise, which
underscores the potential utility of identifying and exploiting the
mediators of these benefits.
Alterations in Heart Structure and Function Induced by
Exercise
In animal models, where conditions can be more rigorously
controlled, exercise increases resistance to and improves recov-
ery from cardiac insults including MI, pressure overload induced
by transverse aortic constriction (TAC), diabetic cardiomyopa-
thy, and doxorubicin cardiotoxicity (Andrews Portes et al.,
2009; Barboza et al., 2013; Chicco et al., 2006; Stølen et al.,
2009). In this section, we will discuss the key cardiac alterations
induced by exercise—from the gross tissue level down tomolec-230 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.ular pathways (Figure 2)—and how they may contribute to the
beneficial effects of exercise. For the sake of scope we will focus
primarily on mechanisms intrinsic to the heart.
At the tissue level, one of the most dramatic and characteristic
effects of exercise on the heart is the induction of cardiac hyper-
trophy, an increase in heart mass evident clinically on non-inva-
sive imaging. In humans, exercise training can increase left
ventricular mass by 20% or more (DeMaria et al., 1978). This hy-
pertrophy is thought to result primarily from cellular hypertrophy
of the cardiomyocytes themselves (Ellison et al., 2012), which
may increase in size by adding new sarcomeres either in parallel
(concentric hypertrophy), thus increasing cardiac wall thickness,
or in series (eccentric hypertrophy), thus increasing chamber
volume. Which form of hypertrophy occurs is influenced by the
type of exercise: the volume challenge caused by endurance
exercise characteristically results in eccentric hypertrophy,
while concentric hypertrophy is more typically induced by the
increased pressure against which the heart must pump during
strength training.
The cardiac hypertrophy induced by exercise appears part of
a beneficial remodeling process, in contrast to the cardiac
hypertrophy observed in disease states such as long-standing
hypertension or after MI. Disease-associated ‘‘pathological hy-
pertrophy’’ is part of an adverse remodeling process including
cardiac fibrosis, electrical remodeling, and activation of a
fetal gene program (Dirkx et al., 2013; Molkentin et al., 1998).
In contrast exercise-induced ‘‘physiological hypertrophy,’’
despite morphological similarities, generally shows none of
these features and is widely believed to be cardioprotective,
except perhaps in extreme cases such as ultra-elite athletes
(La Gerche and Prior, 2007; O’Keefe et al., 2012).
This distinction between physiological and pathological hy-
pertrophy raises the interesting question of why stress placed
on the heart by exercise produces beneficial effects, while
a stress such as hypertension produces adverse ones. One
long-standing line of thought regarding this discordance has
been that it is simply a question of degree: pathological stresses
such as hypertension are generally constant and chronic,
whereas physiological stresses such as exercise are only inter-
mittent. However, pressure overload in animals produces a
more pathological pattern of gene expression than exercise
even when only intermittent (Perrino et al., 2006). These studies
are consistent with more recent work demonstrating that distinct
signaling pathways mediate cardiac growth in physiological and
pathological states and are in some cases antagonistic (Bostro¨m
et al., 2010; DeBosch et al., 2006; McMullen et al., 2007).
As noted above, cardiac output increases during exercise to
accommodate the increased perfusion requirements of exer-
cising muscle. This rise in output increases the three main deter-
minants of myocardial oxygen demand: heart rate, myocardial
contractility, and ventricularwork. As a consequence, intense ex-
ercise can increase the left ventricular oxygen requirement by up
to 6-fold, which ismet primarily by increased coronary blood flow
and, to a lesser extent, by increased oxygen extraction (Duncker
and Bache, 2008). While a complete discussion of the vascular
effects of exercise is beyond the scope of this Perspective, it is
worth highlighting the importance of key components of this
vascular response. Exercise concordantly increases endothe-
lium-dependent coronary vasodilation (Hambrecht et al., 2000),
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Figure 2. Responses of the Heart to Exercise
(A) Organ-level responses of the heart to exercise. Exercise stimulates increases in heart size, resistance to and recovery from injury, vascularization, and output.
(B) Cellular responses to exercise. Exercise stimulates cardiomyocyte hypertrophy, increases mitochondrial biosynthesis, calcium sensitivity, and contractility,
and may drive cardiomyocyte proliferation.
(C) Signaling pathways involved in the cardiac exercise response. Exercise activates the IGF1-PI3K-Akt cascade. Signals then converge at the level of the
nucleus, resulting in inhibition of the transcription factor C/EBPb. Downregulation of C/EPBb, in turn, frees serum response factor to bind target gene promoters,
contributing to activation of an exercise gene set, and, ultimately, cardiac growth. Meanwhile, activation of Cited4may drive cardiomyocyte proliferation, as does
signaling through Nrg1 and ErbB4. Akt also mediates angiogenesis and vascular remodeling via eNOS and exerts beneficial metabolic effects through cross-talk
with AMPK, Sirt1, and PGC-1a. AMPK, AMP-activated kinase; b3-AR, b3 adrenergic receptor; C/EBPb, CCAAT/enhancer binding protein b; Cited4, cbp/p300-
interacting transactivator with Glu/Asp-rich carboxy-terminal domain 4; eNOS, endothelial nitric oxide synthase; IGF-1, insulin-like growth factor-1; NO, nitric
oxide; Nrg1, neuregulin1; PGC-1 a, peroxisome proliferator activated receptor gamma co-activator 1a; PI3K, phosphoinositide-3 kinase; Sirt1, Sirtuin 1; SRF,
serum response factor.
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genesis, and vessel diameters, resulting in increased total
vascular cross-sectional area (White et al., 1998) andmyocardial
perfusion (Hambrecht et al., 2000). In response to exercise
training following MI, these improvements are associated with
improved cardiac function and decreased adverse remodeling
(Leosco et al., 2008).
Cellular Alterations Induced by Exercise
The primary function of cardiomyocytes is to rhythmically con-
tract and relax, a process controlled at the cellular level largely
by cyclically varying Ca2+ levels. Exercise improves cardiomyo-
cyte contractility and Ca2+ sensitivity (Wisløff et al., 2001). In
animals, exercise training can increase cardiomyocyte fractional
shortening by up to 40%–50%, while increasing the rates of both
contraction and relaxation (Kemi and Wisløff, 2010). Some of
these improvements are explained by an increase in the activity
of the sarcoplasmic reticulum Ca2+ ATPase 2a (SERCA2a),
which is primarily responsible for re-uptake of cytoplasmic cal-
cium into the sarcoplasmic reticulum, leading to cardiomyocyte
relaxation. This increase in activity results from both increased
SERCA2a expression and increased phosphorylation (inhibition)
of phospholamban, which binds and inhibits SERCA2a, and is in
direct contrast to the decreased SERCA2a activity characteristi-
cally observed in pathological cardiac remodeling and heart fail-
ure (Fargnoli et al., 2013; Kemi et al., 2007a). These benefits are
seen even in the context of cardiac injury and heart failure, whereaerobic endurance training can restore contractile function,
intracellular Ca2+ handling, and Ca2+ sensitivity in cardiomyo-
cytes from rats with MI (Wisløff et al., 2002). Exercise can also
affect transverse (T)-tubules, invaginations of the plasma mem-
brane that allow depolarization and Ca2+ entry to occur more
rapidly and uniformly across the cardiomyocyte. The organiza-
tion, density, or both of T-tubules have been reported to
decrease in pathologic hypertrophy and cardiac dysfunction
(Guo et al., 2013; Kemi et al., 2011; Louch et al., 2006; Song
et al., 2006), potentially impairing excitation-contraction (EC)
coupling efficiency and contractile function (Guo et al., 2013;
Song et al., 2006), and these decreases can be at least partially
reversed by exercise training (Kemi et al., 2011).
Powering this contractile activity requires an enormous
amount of chemical energy, derived primarily from the oxidation
of fatty acids. During pathological remodeling of the heart cardi-
omyocytes revert to amore fetal metabolic state, reducingmeta-
bolism of fatty acids and shifting back toward a reliance on
glycolysis as the primary pathway for energy production (Leh-
man and Kelly, 2002). Pathological remodeling is also associated
with decreased expression of the key mitochondrial regulator
PGC-1a and its targets (Barger et al., 2000). Experiments with
PGC-1a-deficient mice suggest this downregulation is maladap-
tive, leading to reducedmitochondrial function and defects in the
ability of the heart to respond to increased demand (Arany et al.,
2005; Arany et al., 2006). In contrast, physiological hypertrophyCell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc. 231
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upregulates PGC-1a, AMPK, andmitochondrial biogenesis (Vet-
tor et al., 2014). Interestingly, exercising rats after MI restored
cardiac energymetabolism,mainly at the level of energy transfer:
exercise training corrected depressed expression of adenylate
kinase, restored creatine kinase activity levels, and partially
restored citrate synthase activity (Kemi et al., 2007b).
In addition to improving the function of existing cardiomyo-
cytes, recent work raises the possibility that exercise may also
stimulate cardiomyogenesis in the adult heart. There is a meas-
ureable, albeit low, rate of formation of new cardiomyocytes
in adult mammalian hearts (Ali et al., 2014; Bergmann et al.,
2009; Senyo et al., 2013), which appears to increase after MI,
particularly in the peri-infarct region (Senyo et al., 2013; Smart
et al., 2011). We found that an intensive swimming protocol in
mice not only induced cardiomyocyte and cardiac hypertrophy,
but also increased markers of proliferation in cardiomyocytes
including PCNA expression, positivity for Ki67, phosphorylated
histone H3 (pHH3), and Aurora B kinase staining, and BrdU
incorporation, while others have reported that swimming or
treadmill running increases the number and activation of c-kit+
and Sca-1+ cells, putative cardiac progenitor/stem cell popula-
tions, and induces the formation of small, mononuclear BrdU+
cardiomyocytes (Bostro¨m et al., 2010; Waring et al., 2014; Xiao
et al., 2013). Exercise has also been found to increase cardiac
mRNA and protein levels of neuregulin and periostin, which
have been reported by some to induce cardiomyocytes to re-
enter the cell cycle, although these findings have not been
consistently confirmed (Bersell et al., 2009; Ku¨hn et al., 2007;
Lorts et al., 2009; Waring et al., 2014). The number, origin, and
fate of any new cardiomyocytes formed in response to exercise
remain unclear and will require more detailed cell fate-mapping
studies to address.
Molecular Mechanisms Mediating the Benefits of
Exercise
Exercise triggers increased IGF-1 and neuregulin production in a
variety of tissues, including the heart, leading to increased auto-
crine and paracrine signaling (Frystyk, 2010; Neri Serneri et al.,
2001). Increased cardiac IGF-1 signaling appears to be a strong
driver of physiological hypertrophy, as cardiac-specific IGF-1
transgenic mice develop larger hearts during adulthood with
a greater number of cardiomyocytes, and cardiac-specific over-
expression of IGF-1’s tyrosine kinase receptor IGF-1R results
in increased chamber weight, increased myocyte size, and
improved systolic function without histological signs of pathol-
ogy (McMullen et al., 2004; Reiss et al., 1996). IGF-1 overexpres-
sion also protects mice against a broad range of cardiac insults
including diabetic cardiomyopathy, angiotensin II-mediated
oxidative stress, chronic ischemia, and ischemia-reperfusion
injury (Kajstura et al., 2001; Li et al., 1999; Yamashita et al.,
2001). Neuregulin-1 (NRG-1) signaling through the ErbB family
of tyrosine kinase receptors produces a similar spectrum of car-
dioprotective effects, which has prompted multiple clinical trials
evaluating the use of recombinant NRG-1 fragments for heart
failure treatment (Odiete et al., 2012). In addition to being suffi-
cient to recapitulate many of the cardiac benefits of exercise,
IGF-1 signaling is necessary for exercise-induced cardiac hyper-
trophy as demonstrated by swim training of cardiac-specific
IGF-1R knockout mice (Kim et al., 2008).232 Cell Metabolism 21, February 3, 2015 ª2015 Elsevier Inc.IGF-1R activates PI3-kinase (PI3K), a family of heterodimeric
kinases composed of regulatory and catalytic subunits, of which
the PI3K (110a) isoform appears necessary and sufficient for
mediating the cardiac effects of exercise and IGF-1 signaling
(Matsui et al., 2003; McMullen et al., 2004). Cardiac-specific
expression of dominant-negative PI3K (110a) (dnPI3K) inhibited
cardiac growth in response to exercise, but did not affect
pathological hypertrophy in response to TAC (McMullen et al.,
2003). Interestingly, dnPI3K also abolished exercise-induced
protection against pressure overload, while expression of consti-
tutively-active PI3K (110a) protected the mice regardless of
exercise status, suggesting that PI3K (110a) is necessary and
sufficient for exercise-induced protection against adverse re-
modeling in this setting (Weeks et al., 2012).
The serine-threonine protein kinase Akt1 functions down-
stream of PI3K to mediate physiological hypertrophy and many
of the cardiac benefits of exercise. Interestingly, germline Akt1
knockout mice are resistant to swimming-induced cardiac
growth while exhibiting an exaggerated hypertrophic response
to TAC, suggesting Akt1 is necessary for physiological cardiac
hypertrophy, but antagonizes pathological hypertrophy (De-
Bosch et al., 2006). Akt1 is also sufficient to protect cardiomyo-
cytes against apoptosis and preserve function in vitro and in vivo
(Matsui et al., 1999, 2001).
With regard to the effects of exercise, an important fac-
tor downstream of Akt1 appears to the transcription factor
C/EBPb, as we found when performing a genome-wide expres-
sion analysis of all transcriptional components in exercised
hearts compared to hearts post-TAC (Bostro¨m et al., 2010).
Exercise downregulated cardiomyocyte C/EBPb expression,
as did overexpression of Akt1 in vitro, while C/EBPb overexpres-
sion blocked Akt1-induced expression of genes characteristic of
physiological hypertrophy. Mimicking this reduction in C/EBPb
genetically resulted in a phenocopy of endurance exercise,
and mice heterozygous for C/EBPb were also resistant to heart
failure after pressure overload (Bostro¨m et al., 2010). These ef-
fects of C/EBPb appear to be at least in part through regulating
expression of CBP/p300-interacting transactivator with ED-rich
carboxy-terminal domain 4 (CITED4), though the mechanism
downstream of Cited4 is as yet unknown (Bostro¨m et al., 2010).
Sirtuins, a family of nicotinamide adenine dinucleotide (NAD)-
dependent deacetylases, have also been implicated in medi-
ating the cardiac effects of exercise. Of the seven sirtuins found
in mammals, Sirt1 and Sirt3 are the best studied with regard to
the cardiac effects of exercise. Both are upregulated in the heart
by exercise (Lai et al., 2014; Sundaresan et al., 2009). Sirt1 acti-
vates Akt1 and PGC-1a among other pathways and protects
mice against cardiac ischemia/reperfusion injury, while Sirt3 pro-
tects against cardiac oxidative stress in a Foxo3a-dependent
manner, regulates cardiomyocyte metabolism through activa-
tion of AMPK and PGC-1a, and causes resistance to angio-
tensin-II-driven cardiac hypertrophy and fibrosis (Ferrara et al.,
2008; Hsu et al., 2010; Pillai et al., 2010; Sundaresan et al.,
2009, 2011).
The protection that exercise training provides against
ischemic injury also appears to occur through regulation of
endothelial nitric oxide synthase (eNOS). Exercise results in
increased circulating catecholamines such as epinephrine
and norepinephrine, which act on b3-adrenergic receptors to
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Perspectiveincrease eNOS phosphorylation and activity, in turn increasing
the bioavailability of the NO metabolites nitrite and nitrosothiol
(Calvert et al., 2011). Phosphorylation of eNOS at serine residue
1,177, which increases its activity, is also promoted by Akt and
AMPK in response to treadmill running (Zhang et al., 2009).
Increased eNOS expression attenuates congestive heart failure
in mice, while mice with heterozygous or homozygous knockout
of eNOS do not experience the cardiac benefits of exercise after
MI observed in wild-type mice (Calvert et al., 2011), although the
later result is potentially confounded by a reduction in the exer-
cise levels achieved by the knockout mice (Bezzerides and
Rosenzweig, 2011; de Waard et al., 2010; Jones et al., 2003).
Interesting results have also begun to emerge implicating
miRNAs in the regulation of cardiac hypertrophy and response
to exercise. Both cardiac and circulating miRNA levels are regu-
lated in response to exercise (Baggish et al., 2014; Ma et al.,
2013), and in vitro screening has identified miRNAs with pro-
and anti-hypertrophic effects on neonatal rat cardiomyocytes
(Jentzsch et al., 2012). However, experiments testing the neces-
sity and sufficiency of the observed changes in miRNA levels for
the various phenotypic effects of exercise have so far been
scarce, and this will likely be a productive area for future work.
Conclusion
As we have highlighted, the study of exercise has yielded many
insights into cardiac biology, particularly with regard to the
mechanisms by which the heart responds to stress. Exercise
studies complement studies of disease, and when used as
platforms for unbiased screening, exercise models will likely
generate candidate gene lists largely distinct from those pro-
duced by studies of cardiac pathologies. To maximize the
reliability of future exercise studies and the extent to which their
results can be productively compared to other data sets, we urge
detailed reporting of exercise protocols and validation, taking
into account the design criteria and limits discussed above. Ulti-
mately a deeper understanding of how the beneficial cardiac re-
sponses to physiological stress differ from and protect against
pathological stressors may provide a foundation for new thera-
peutic approaches for the treatment of heart disease. While the
multifactorial nature of the exercise response suggests that
developing a simple ‘‘exercise-in-a-pill’’ treatment may not be
feasible, even partial recapitulation of the benefits of exercise
by pharmacological intervention could provide an important
new component of treatment for patients too sick to exercise.
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